Beam Therapeutics Inc. (BEAM) stock
BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3014% below fair value
$20.65−0.29 (-1.38%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Beam Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Beam Therapeutics's market cap was $2.67B on Nov 11, 2026, against $2.57B a year earlier. Over the last 5 years it ranged from $1.59B to $5.40B, with a median of $2.52B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.67B | -5.1% |
| 2025 | Dec 31, 2025 | $2.81B | +37.2% |
| 2024 | Dec 31, 2024 | $2.05B | -5.2% |
| 2023 | Dec 29, 2023 | $2.16B | -21.6% |
| 2022 | Dec 30, 2022 | $2.76B | -48.9% |
| 2021 | Dec 31, 2021 | $5.40B | +31.1% |
| 2020 | Dec 31, 2020 | $4.12B | – |
See a number that looks wrong?